Written informed consent obtained
Male and female subjects aged 20 years or older at informed consent
Essential hypertension who had never received angiotensin II receptor antagonists and calcium channel blockers

NCT02996916_inc_T2
Person
Male
NCT02996916_inc_T3
Person
female
NCT02996916_inc_T4
Person
aged
NCT02996916_inc_T5
Value
20 years or older
NCT02996916_inc_T6
Temporal
at informed consent
NCT02996916_inc_T7
Reference_point
informed consent
NCT02996916_inc_T8
Condition
Essential hypertension
NCT02996916_inc_T9
Drug
angiotensin II receptor antagonists
NCT02996916_inc_T10
Drug
calcium channel blockers
NCT02996916_inc_T11
Negation
never
NCT02996916_inc_T12
Scope
angiotensin II receptor antagonists and calcium channel blockers